ICL Israel Chemicals Reports Q3 Results

Investor Overview
ICL Israel Chemicals (NYSE: ICL) reported a third-quarter EPS of $0.110, exceeding the analyst estimate of $0.082 by $0.03. Revenue for the quarter came in at $1.75B, slightly below the consensus estimate of $1.85B.

Stock Performance
ICL Israel Chemicals's stock price closed at $4.14. The stock has declined by -1.66% over the last 3 months and -15.34% over the last 12 months.

Earnings Revisions
In the past 90 days, ICL Israel Chemicals experienced 0 positive EPS revisions and 4 negative EPS revisions.

Financial Health
According to InvestingPro, ICL Israel Chemicals's Financial Health score indicates great performance.

For more insights on ICL Israel Chemicals's recent earnings and financials, visit Investing.com's earnings calendar.